Effects of adenosine on bacterial lipopolysaccharide- and interleukin 1-induced nitric oxide release from equine articular chondrocytes

American Journal of Veterinary Research

Volumn 63, Issue 2, 2002, Pages 204-210

  Benton, Hilary P ^a   MacDonald, Melinda H ^a   Tesch, Anthony M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE RECEPTOR STIMULATING AGENT; ADENYLATE CYCLASE; ARGININE; BACTERIUM LIPOPOLYSACCHARIDE; BRADYKININ; CALCIMYCIN; CALCIUM IONOPHORE; CELL PROTEIN; CITRULLINE; FORSKOLIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; RECOMBINANT INTERLEUKIN 1ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTHRITIS; ARTHROPATHY; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CELL DENSITY; CELL DIFFERENTIATION; CELL ISOLATION; CHEMICAL REACTION; CONTROLLED STUDY; ENZYME ACTIVITY; HORSE; IN VITRO STUDY; ISOTOPE LABELING; METACARPOPHALANGEAL JOINT; METATARSOPHALANGEAL JOINT; NONHUMAN; SECOND MESSENGER; SUPERNATANT; SURGICAL TECHNIQUE;

ANIMALIA; BACTERIA (MICROORGANISMS); EQUIDAE; EQUUS CABALLUS;

EID: 0036486653     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2002.63.204     Document Type: Article

References (49)

1. Barankiewicz J, Jimenez R, Uyesaka J, et al. Endogenous adenosine formation can regulate human neutrophil function. Adv Exp Med Biol 1994;370:417-421.
2. 2 receptors. J Immunol 1992;148:2201-2206.
3. Gruber HE, Hoffer ME, McAllister DR, et al. Increased adenosine concentration in blood from ischemic myocardium by AICA-riboside. Effects on flow, granulocytes, and injury. Circulation 1989;80:1400-1411.
4. 2A receptor monoclonal antibodies. Mol Pharmacol 1999:55:614-624.
5. 1 receptor promotion of multinucleated giant cell formation by human monocytes: a mechanism for methotrexate-induced nodulosis in rheumatoid arthritis. Arthritis Rheum 1997;40:1308-1315.
6. Zalavary S, Bengtsson T. Modulation of the chemotactic peptide- and immunoglobulin G-triggered respiratory burst in human neutrophils by exogenous and endogenous adenosine. Eur J Pharmacol 1998;354:215-225.
7. Bouma MG, Stad RK, van den Wildenbeyg FA, et al. Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J Immunol 1994;153:4159-4168.
8. Bouma MG, van den Wildenberg FA, Buurman WA. Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells. Am J Physiol 1996;270:522-529.
9. Le Moine O, Stordeur P, Schandene L, et al. Adenosine enhances IL-10 secretion by human monocytes. J Immunol 1996;156:4408-4414.
10. 2 receptors, adenosine inhibits production of tumor necrosis factor-α of endotoxin-stimulated polymorphonuclear leukocytes. J Lab Clin Med 1995;126:275-282.
11. 2 receptor-induced inhibition of leukotriene B4 synthesis in whole blood ex vivo. Br J Pharmacol 1996;117:1639-1644.
12. Cronstein BN, Kramer SB, Weissmann G. Adenosine: a physiological modulator of superoxide anion generation by human neutrophils. J Exp Med 1983;158:1160-1177.
13. Cronstein BN, Naime D, Ostad E. The antiinflammatory mechanism of methotrexate: increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vitro model of inflammation. J Clin Invest 1993;92:2675-2682.
14. Gadangi P, Longaker M, Naime D, et al. The anti-inflammatory mechanism of sulfasalazine is related to adenosine release at inflamed sites. J Immunol 1996;156:1937-1941.
15. Cronstein BN. The mechanism of action of methotrexate. Rheum Dis Clin North Am 1997;23:739-755.
16. Kremer MJ. The mechanism of action of methotrexate in rheumatoid arthritis: the search continues. J Rheumatol 1994;21:1-5.
17. Cronstein BN, Montesinos MC, Weissman G. Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkappaB. Proc Natl Acad Sci U S A 1999;96:6377-6381.
18. Koolpe M, Pearson, D, Benton HP. Expression of both P1 and P2 purine receptor genes by human articular chondrocytes and profile of ligand-mediated prostaglandin E2 release. Arth Rheum 1999;42:258-267.
19. Drury AN, Szent-Gyorgyi A. The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J Physiol 1929;68:213-237.
20. Burnstock G. Overview. Purinergic mechanisms. Ann N Y Acad Sci 1990;603:1-18.
21. Olah ME, Stiles GL. Adenosine receptor subtypes: characterization and therapeutic regulation. Ann Rev Pharmacol Toxicol 1995;35:581-606.
22. Kowaluk EA, Bhagwat SS, Jarvis MF. Adenosine kinase inhibitors. Curr Pharm Des 1998;4:403-416.
23. Collis MG, Hourani MO. Adenosine receptor subtypes. Trends Pharmacol Sci 1993;14:360-366.
24. Hon WM, Khoo HE, Ngoi SS, et al. Effects of adenosine receptor agonists on nitric oxide release in mouse during endotoxemia. Biochem Pharmacol 1995;50:45-47.
25. Cronstein BN, Eberle MA, Gruber HE, et al. Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc Natl Acad Sci U S A 1991;88:2441-2445.
26. Cronstein BN, Naime D, Firestein GS. The antiinflammatory effects of an adenosine kinase inhibitor are mediated by adenosine. Arthritis Rheum 1995;38:1040-1045.
27. 3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem 1993;268:16887-16890.
28. 2 release from human rheumatoid synovial cells. Arthritis Rheum 1988;41:246-255.
29. Koolpe M, Benton HP. Calcium-mobilizing purine receptors on the surface of mammalian articular chondrocytes. J Orthop Res 1997;15:204-212.
30. Koolpe M, Rodrigo JJ, Benton HP. Adenosine 5′-triphosphate, uridine 5′-triphosphate, bradykinin, and lysophosphatidic acid induce different patterns of calcium responses by human articular chondrocytes. J Orthop Res 1998;16:217-226.
31. Hatori M, Teixeira CC, Debolt K, et al. Adenine nucleotide metabolism by chondrocytes in vitro: role of ATP in chondrocyte maturation and matrix mineralization. J Cell Physiol 1995;165:468-474.
32. i in retinoic acid-treated embryonic chondrocytes. Am J Physiol 1997;272:C1611-C1617.
33. i and enhance basic fibroblast growth factor-induced proliferation in sheep chondrocytes. Endocrinology 1996;137:4757-4766.
34. 2-purinoceptors. Biochim Biophys Acta 1994;1201:298-304.
35. 2-purinoceptors at the surface of human articular chondrocytes in monolayer culture. Biochim Biophys Acta 1991;1074:151-158.
36. Boyle DL, Sajjadi FG, Firestein GS. Inhibition of synoviocyte collagenase gene expression by adenosine receptor stimulation. Arthritis Rheum 1996;39:923-930.
37. Szabo C, Scott GS, Virag L, et al. Suppression of macrophage inflammatory protein (MIP)-lalpha production and collagen-induced arthritis by adenosine receptor agonists. Brit J Pharmacol 1998;125:379-387.
38. Studer R, Jaffurs D, Stefanovic-Racic M, et al. Nitric oxide in osteoarthritis. Osteoarthritis Cartilage 1999;7:377-379.
39. Clancy RM, Amin AR, Abramson SB. The role of nitric oxide in inflammation and immunity. Arthritis Rheum 1998;41:1141-1151.
40. Evans CH, Stefanovic-Racic M, Lancaster J. Nitric oxide and its role in orthopaedic disease. Clin Orthop Rel Res 1995;312:275-294.
41. Benton HP, Jackson TR, Hanley MR. identification of a novel inflammatory stimulant of chondrocytes. Early events in cell activation by bradykinin receptors on pig articular chondrocytes. Biochem J 1989;258:861-867.
42. Cheng TC, Benton HP. The intracellular Ca (2+)-pump inhibitors thapsigargin and cyclopiazonic acid induce stress proteins in mammalian chondrocytes. Biochem J 1994;301:563-568.
43. 15N]nitrate in biological fluids. Anal Biochem 1982;126:131-138.
44. MacDonald MH, Stover SM, Willits NH, et al. Regulation of matrix metabolism in equine cartilage explant cultures by interleukin 1. Am J Vet Res 1992;53:2278-2285.
45. 2 synthesis in equine cartilage explant cultures. Am J Vet Res 1994;55:1127-1138.
46. Bird JL, May S, Bayliss MT. Nitric oxide inhibits aggrecan degradation in explant cultures of equine articular cartilage. Equine Vet J 2000;32:133-139.
47. Squadrito GL, Pryor WA. Oxidative chemistry of nitric oxide: the roles of superoxide, peroxynitrite, and carbon dioxide. Free Radic Biol Med 1998;25:392-403.
48. Oh A, Fukuda K, Asada S, et al. Concurrent generation of nitric oxide and superoxide inhibits proteoglycan synthesis in bovine articular chondrocytes: involvement of peroxynitrite. J Rheumatol 1998;25:2169-2174.
49. Salvemini D, Manning PT, Zweifel BS, et al. Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors. J Clin Invest 1995;96:301-308.